Stockscreener 앱 받기
0.38
15.27%
-0.0685
시간 외 거래:
.37
-0.01
-2.63%
전일 마감가:
$0.4485
열려 있는:
$0.44
하루 거래량:
310.90K
Relative Volume:
0.04
시가총액:
$8.57M
수익:
$9.37M
순이익/손실:
$-8.45M
주가수익비율:
-0.4691
EPS:
-0.81
순현금흐름:
$-7.27M
1주 성능:
-19.11%
1개월 성능:
-44.40%
6개월 성능:
-71.64%
1년 성능:
-81.82%
1일 변동 폭
$0.3601
$0.44
1주일 범위
$0.3601
$0.48
52주 변동 폭
$0.2404
$2.9893
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
명칭
Bioaffinity Technologies Inc
전화
210-698-5334
주소
3300 NACOGDOCHES ROAD, SAN ANTONIO
BIAF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.38 | 8.57M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
422.27 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.40 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
475.07 | 34.90B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
108.37 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
152.30 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
bioAffinity Technologies (NASDAQ:BIAF) Shares Up 2.7% – Still a Buy? - Defense World
bioAffinity Technologies streamlines lung cancer detection test By Investing.com - Investing.com Canada
bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost - BioSpace
bioAffinity Technologies streamlines lung cancer detection test - Investing.com
Bioaffinity Technologies Increases Efficiency Of Cypath Lung Test - marketscreener.com
Revolutionary Lung Cancer Detection Test Achieves 92% Accuracy While Slashing Costs by 25% - Stock Titan
ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Joplin Globe
bioAffinity Technologies Board Member Announces Departure - TipRanks
CyPath Lung Helped Detect Breast Cancer Recurrence - Medical Product Outsourcing
Bioaffinity Technologies Files For Resale Of Up To 3.0 Million Shares Of Common Stock By Selling StockholdersSEC Filing - marketscreener.com
bioAffinity Technologies Reports Record Revenue for 2024 - TipRanks
BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues - Yahoo Finance
Earnings roundup: Usio back in the black; losses widen at bioAffinity, Wytec - San Antonio Express-News
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Joplin Globe
bioAffinity Technologies Stock Price, Quotes and Forecasts | NASDAQ:BIAF - Benzinga
Best Biotech Stocks To Follow Today – April 1st - Defense World
Biotech stock bioAffinity Technologies, Inc. (NASDAQ: BIAF) Makes NASDAQ Top Percentage Gainer on News - Investorideas.com
Take off with BioAffinity Technologies Inc (BIAF): Get ready for trading - Sete News
bioAffinity Technologies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
bioAffinity Technologies (NASDAQ:BIAF) Given Hold Rating at Maxim Group - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Lung cancer spit test fast-tracks a San Antonio biotech company for growth - MSN
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Nasdaq Surges 1%; US Construction Spending Rises In February - Benzinga
Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - Benzinga
What's Going On With BioAffinity Shares Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
bioAffinity Technologies stock hits 52-week low at $0.25 By Investing.com - Investing.com South Africa
bioAffinity Technologies, Inc. SEC 10-K Report - TradingView
bioAffinity Technologies earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
bioAffinity posts 270% revenue rise with Medicare coverage - Investing.com
bioAffinity Technologies stock hits 52-week low at $0.25 - Investing.com
bioAffinity posts 270% revenue rise with Medicare coverage By Investing.com - Investing.com India
Record-Breaking 270% Revenue Surge: bioAffinity's Growth Story Takes Unexpected Turn - Stock Titan
bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024 - The Joplin Globe
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer - BioSpace
BIOAFFINITY TECHNOLOGIES Earnings Preview: Recent $BIAF Insider Trading, Hedge Fund Activity, and More - Nasdaq
Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer - Business Wire
bioAffinity Technologies (NASDAQ:BIAFW) Shares Down 24.3% – Here’s What Happened - Defense World
bioAffinity stock hits 52-week low at $0.26 amid market challenges - Investing.com Australia
BioAffinity Technologies Inc (BIAF): An Important Analyst Insights - Stocks Register
Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence - BioSpace
bioAffinity stock hits 52-week low at $0.26 amid market challenges By Investing.com - Investing.com South Africa
bioAffinity Technologies Cutting Jobs to Save $4 Million in Operating Costs - MPO-mag
Bioaffinity Technologies Inc (BIAF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.34%
0.46%
자본화:
|
볼륨(24시간):